UBS Downgrades Accretive Health (AH) to Neutral
Tweet
Share
E-mailGet Alerts AH Hot Sheet
Price: $8.02 --0%
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS downgraded Accretive Health (NYSE: AH) from Buy to Neutral.
For an analyst ratings summary and ratings history on Accretive Health click here. For more ratings news on Accretive Health click here.
Shares of Accretive Health closed at $10.06 yesterday.
For an analyst ratings summary and ratings history on Accretive Health click here. For more ratings news on Accretive Health click here.
Shares of Accretive Health closed at $10.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- JPMorgan Downgrades KinderCare Learning Companies (KLC) to Underweight
- Barclays Downgrades Murphy Oil Corp. (MUR) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
